Mark L. Jacobson, Chief Operating Officer at Axsome Therapeutics, Inc. (AXSM), sold 10,000 shares at $208.65 ($2.1M) on 2026-09-03, disclosed to the SEC on 2026-09-03.
Scheduled sale ($2.1M) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| AXSM | SELL | 2025-09-22 | $1.2M | — | Filing → |
| AXSM | SELL | 2025-09-17 | $5.9M | — | Filing → |
| AXSM | SELL | 2025-06-10 | $2.8M | — | Filing → |